臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"liau j y"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 1-25 / 260 (共11頁)
1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2022-08-19T00:21:02Z	Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin	Cheng A.-L.; Lin C.-H.; Chang K.-J.; Kuo W.-H.; CHIUN HSU; Lee W.-C.; Liau J.-Y.; Huang C.-S.; Lu Y.-S.; Shao Y.-Y.; Kuo K.-T.; Hu F.-C.
臺大學術典藏	2022-08-12T06:27:57Z	Molecular subtypes of breast cancer emerging in young women in Taiwan: Evidence for more than just westernization as a reason for the disease in Asia	Lin C.-H.; Liau J.-Y.; Lu Y.-S.; Huang C.-S.; Lee W.-C.; Kuo K.-T.; Shen Y.-C.; Kuo S.-H.; Lan C.; Liu J.M.; Kuo W.-H.; KING-JEN CHANG; Cheng A.-L.
臺大學術典藏	2022-08-12T06:27:55Z	Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin	Shao Y.-Y.; Kuo K.-T.; Hu F.-C.; Lu Y.-S.; Huang C.-S.; Liau J.-Y.; Lee W.-C.; Hsu C.; Kuo W.-H.; KING-JEN CHANG; Lin C.-H.; Cheng A.-L.
臺大學術典藏	2022-05-13T08:04:07Z	Lymphadenopathy Associated with Neutralizing Anti-interferon-gamma Autoantibodies Could Have Monoclonal T-cell Proliferation Indistinguishable from Malignant Lymphoma and Treatable by Antibiotics: A Clinicopathologic Study	Yuan C.-T.; JANN-TAY WANG; Sheng W.-H.; Cheng P.-Y.; Kao C.-J.; Wang J.-Y.; Chen C.-Y.; Liau J.-Y.; Tsai J.-H.; Lin Y.-J.; Chen C.-C.; Chen Y.-C.; Chang S.-C.; Wu U.-I.
臺大學術典藏	2022-03-10T07:58:45Z	Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer	Lin Y.-L.; Liau J.-Y.; Yu S.-C.; LI-HUI TSENG; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏	2022-03-10T07:58:45Z	KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells	Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Ou D.-L.; Lin L.-I.; LI-HUI TSENG; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏	2022-03-10T07:58:43Z	Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients	Lin Y.-.; Liang Y.-H.; Tsai J.-H.; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; LI-HUI TSENG; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏	2022-03-10T07:58:41Z	Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations	Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; LI-HUI TSENG; Lin L.-I.; Chang Y.-L.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏	2022-03-10T07:58:41Z	Aberrant expression of annexin A10 is closely related to gastric phenotype in serrated pathway to colorectal carcinoma	Tsai J.-H.; Lin Y.-L.; Cheng Y.-C.; Chen C.-C.; Lin L.-I.; LI-HUI TSENG; Cheng M.-L.; Liau J.-Y.; Jeng Y.-M.
臺大學術典藏	2022-03-10T07:58:39Z	RNF43 is an early and specific mutated gene in the serrated pathway, with increased frequency in traditional serrated adenoma and its associated malignancy	Tsai J.-H.; Liau J.-Y.; Yuan C.-T.; Lin Y.-L.; LI-HUI TSENG; Cheng M.-L.; Jeng Y.-M.
臺大學術典藏	2022-03-10T07:58:38Z	BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer	Chen K.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; LI-HUI TSENG; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏	2022-03-10T07:58:38Z	Frequent BRAF mutation in early-onset colorectal cancer in Taiwan: Association with distinct clinicopathological and molecular features and poor clinical outcome	Tsai J.-H.; Liau J.-Y.; Lin Y.-L.; LI-HUI TSENG; Lin L.-I.; Yeh K.-H.; Jeng Y.-M.
臺大學術典藏	2022-03-10T07:58:36Z	CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer	Chen K.-H.; Lin L.-I.; LI-HUI TSENG; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏	2022-03-10T05:59:39Z	Preoperative prediction of papillary thyroid carcinoma prognosis with the assistance of computerized morphometry of cytology samples obtained by fine-needle aspiration: Preliminary report	Shih S.-R.; YI-CHENG CHANG; Li H.-Y.; Liau J.-Y.; Lee C.-Y.; Chen C.-M.; Chang T.-C.
臺大學術典藏	2022-03-04T05:33:38Z	Dedifferentiated liposarcoma with homologous lipoblastic differentiation: Expanding the spectrum to include low-grade tumours	Liau J.-Y.; Lee J.-C.; CHEN-TU WU; Kuo K.-T.; Huang H.-Y.; Liang C.-W.
臺大學術典藏	2022-02-18T08:46:54Z	Aberrant expression of annexin A10 is closely related to gastric phenotype in serrated pathway to colorectal carcinoma	Tsai J.-H.; Lin Y.-L.; Cheng Y.-C.; CHIEN-CHUAN CHEN; Lin L.-I.; Tseng L.-H.; Cheng M.-L.; Liau J.-Y.; Jeng Y.-M.
臺大學術典藏	2022-02-18T08:46:51Z	Traditional serrated adenoma with BRAF mutation is associated with synchronous/metachronous BRAF-mutated serrated lesions	Tsai J.-H.; Cheng C.-H.; CHIEN-CHUAN CHEN; Lin Y.-L.; Lin L.-I.; Chen M.-L.; Liau J.-Y.
臺大學術典藏	2022-02-15T05:45:02Z	Lymphadenopathy Associated with Neutralizing Anti-interferon-gamma Autoantibodies Could Have Monoclonal T-cell Proliferation Indistinguishable from Malignant Lymphoma and Treatable by Antibiotics: A Clinicopathologic Study	Yuan C.-T.; Wang J.-T.; Sheng W.-H.; Cheng P.-Y.; Kao C.-J.; Wang J.-Y.; Chen C.-Y.; Liau J.-Y.; Tsai J.-H.; Lin Y.-J.; Chen C.-C.; Chen Y.-C.; Chang S.-C.; UN-IN WU
臺大學術典藏	2022-02-14T07:10:51Z	Molecular features of primary hepatic undifferentiated carcinoma	Tsai J.-H.; YUNG-MING JENG; Lee C.-H.; Liau J.-Y.
臺大學術典藏	2022-02-14T07:10:49Z	Lymphoepithelioma-like Intrahepatic Cholangiocarcinoma Is a Distinct Entity with Frequent pTERT / TP53 Mutations and Comprises 2 Subgroups Based on Epstein-Barr Virus Infection	Tsai J.-H.; Liau J.-Y.; Lee C.-H.; YUNG-MING JENG
臺大學術典藏	2022-02-14T07:10:48Z	Molecular features of primary hepatic undifferentiated carcinoma	JIA-HUEI TSAI; Jeng Y.-M.; Lee C.-H.; Liau J.-Y.
臺大學術典藏	2022-02-14T07:10:47Z	Lymphoepithelioma-like Intrahepatic Cholangiocarcinoma Is a Distinct Entity with Frequent pTERT / TP53 Mutations and Comprises 2 Subgroups Based on Epstein-Barr Virus Infection	JIA-HUEI TSAI; Liau J.-Y.; Lee C.-H.; Jeng Y.-M.
臺大學術典藏	2022-02-14T07:10:47Z	Lymphadenopathy Associated with Neutralizing Anti-interferon-gamma Autoantibodies Could Have Monoclonal T-cell Proliferation Indistinguishable from Malignant Lymphoma and Treatable by Antibiotics: A Clinicopathologic Study	Yuan C.-T.; Wang J.-T.; Sheng W.-H.; Cheng P.-Y.; Kao C.-J.; Wang J.-Y.; Chen C.-Y.; Liau J.-Y.; JIA-HUEI TSAI; Lin Y.-J.; Chen C.-C.; Chen Y.-C.; Chang S.-C.; Wu U.-I.
臺大學術典藏	2021-10-27T03:22:25Z	RNF43 is an early and specific mutated gene in the serrated pathway, with increased frequency in traditional serrated adenoma and its associated malignancy	Tsai J.-H.; Liau J.-Y.; CHANG-TSU YUAN; Lin Y.-L.; Tseng L.-H.; Cheng M.-L.; Jeng Y.-M.
臺大學術典藏	2021-10-27T03:22:24Z	RNF43 mutation frequently occurs with GNAS mutation and mucin hypersecretion in intraductal papillary neoplasms of the bile duct	Tsai J.-H.; Liau J.-Y.; CHANG-TSU YUAN; Cheng M.-L.; Yuan R.-H.; Jeng Y.-M.

顯示項目 1-25 / 260 (共11頁)
1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 51929706 線上人數 : 1164 教育部委託研究計畫計畫執行:國立臺灣大學圖書館